A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model

• Javier Castillo-Olivares ,

  * E-mail: javier.castillo-olivares@bbsrc.ac.uk

  Affiliation Institute for Animal Health, Pirbright, Woking, Surrey, United Kingdom

  ⨯
• Eva Calvo-Pinilla,

  Affiliation Centro en Investigacion y Sanidad Animal (CISA), Valdeolmos, Madrid, Spain

  ⨯
• Isabel Casanova,

  Affiliation Centro en Investigacion y Sanidad Animal (CISA), Valdeolmos, Madrid, Spain

  ⨯
• Katarzyna Bachanek-Bankowska,

  Affiliation Institute for Animal Health, Pirbright, Woking, Surrey, United Kingdom

  ⨯
• Rachael Chiam,

  Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  ⨯
• Sushila Maan,

  Affiliation Institute for Animal Health, Pirbright, Woking, Surrey, United Kingdom

  ⨯
• Jose Maria Nieto,

  Affiliation Centro en Investigacion y Sanidad Animal (CISA), Valdeolmos, Madrid, Spain

  ⨯
• Javier Ortego,

  Affiliation Centro en Investigacion y Sanidad Animal (CISA), Valdeolmos, Madrid, Spain

  ⨯
• Peter Paul Clement Mertens

  Affiliation Institute for Animal Health, Pirbright, Woking, Surrey, United Kingdom

  ⨯